Tacrine (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Tacrine" in English language version.

refsWebsite

Global rank English rank

2^nd place

4^th place

1^st place

3,151^st place

5,932^nd place

800^th place

676^th place

407^th place

241^st place

719^th place

636^th place

bizjournals.com

Taraschenko OD, Barnes WG, Herrick-Davis K, Yokoyama Y, Boyd DL, Hough LB (April 2005). "Actions of tacrine and galanthamine on histamine-N-methyltransferase". Methods and Findings in Experimental and Clinical Pharmacology. 27 (3): 161–165. doi:10.1358/mf.2005.27.3.890872. PMID 15834447.
Qizilbash N, Whitehead A, Higgins J, Wilcock G, Schneider L, Farlow M (November 1998). "Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration". JAMA. 280 (20): 1777–1782. doi:10.1001/jama.280.20.1777. PMID 9842955.
Elks J, Ganellin CR, eds. (1990). Dictionary of Drugs. doi:10.1007/978-1-4757-2085-3. ISBN 978-1-4757-2087-7.
Watkins PB, Zimmerman HJ, Knapp MJ, Gracon SI, Lewis KW (April 1994). "Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease". JAMA. 271 (13): 992–998. doi:10.1001/jama.1994.03510370044030. PMID 8139084.

US 4816456, Summers WK, "Administration of monoamine acridines in cholinergic neuronal deficit states", issued 28 March 1989

Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.

"tacrine (Discontinued) - Cognex". Medscape Reference. WebMD. Archived from the original on 30 June 2019. Retrieved 8 October 2013.

Taraschenko OD, Barnes WG, Herrick-Davis K, Yokoyama Y, Boyd DL, Hough LB (April 2005). "Actions of tacrine and galanthamine on histamine-N-methyltransferase". Methods and Findings in Experimental and Clinical Pharmacology. 27 (3): 161–165. doi:10.1358/mf.2005.27.3.890872. PMID 15834447.
Qizilbash N, Whitehead A, Higgins J, Wilcock G, Schneider L, Farlow M (November 1998). "Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration". JAMA. 280 (20): 1777–1782. doi:10.1001/jama.280.20.1777. PMID 9842955.
Watkins PB, Zimmerman HJ, Knapp MJ, Gracon SI, Lewis KW (April 1994). "Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease". JAMA. 271 (13): 992–998. doi:10.1001/jama.1994.03510370044030. PMID 8139084.

"Tacrine". LiverTox. U.S. National Institutes of Health. Archived from the original on 2019-07-02.

Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
"tacrine (Discontinued) - Cognex". Medscape Reference. WebMD. Archived from the original on 30 June 2019. Retrieved 8 October 2013.
"Tacrine". LiverTox. U.S. National Institutes of Health. Archived from the original on 2019-07-02.